Exactech posts 10 percent jump in second-quarter sales
Published: Tuesday, July 23, 2013 at 4:37 p.m.
Last Modified: Tuesday, July 23, 2013 at 4:37 p.m.
Exactech reported a 10 percent increase in second-quarter sales to $60.6 million compared with $55.2 million in the second quarter of 2012, largely on the strength of shoulder implant sales.
The Gainesville company makes bone and joint restoration products and trades on the Nasdaq stock exchange under the symbol EXAC.
Net income increased 23 percent to $3.7 million, or $0.27 per diluted share, compared with $3 million and $0.23 per share in the second quarter 2012.
Extremity implant sales, which includes the Equinoxe shoulder, increased 36 percent to $16.3 million. Knee implant sales remained flat at $21 million.
U.S. sales increased 13 percent to $39.9 million, while international sales increased 4 percent to $20.7 million.
Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.